메뉴 건너뛰기
Nature Reviews Urology
Volumn 7, Issue 7, 2010, Pages 359-
Prostate cancer: Time to trial statins?

(1)  Farley, Suzanne J a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN;
EID: 77954470453     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.85     Document Type: Article
Times cited : (1)
References (3)
  • 1
    • 77954510532 scopus 로고    scopus 로고
    • Statin use and risk of prostate cancer recurrence in men treated with radiation therapy
    • Gutt, R. et al. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J. Clin. Oncol. 28, 2653-2659 (2010)
    • (2010) J. Clin. Oncol. , vol.28 , pp. 2653-2659
    • Gutt, R.1
  • 2
    • 77954479865 scopus 로고    scopus 로고
    • Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy
    • doi:10.1016/j.ijrobp.2009.12.006
    • Kollmeier, M. A. et al. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. doi:10.1016/j.ijrobp.2009.12.006
    • Int. J. Radiat. Oncol. Biol. Phys.
    • Kollmeier, M.A.1
  • 3
    • 77955513656 scopus 로고    scopus 로고
    • Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer
    • doi:10.1016/.eururo.2010.05.024
    • Wang, C. et al. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur. Urol. doi:10.1016/ j.eururo.2010.05.024
    • Eur. Urol.
    • Wang, C.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.